We have relaunched our website to bring our 12 hospital sites into one place. You can still get care at your preferred Mass General Brigham location; it's just easier to find them online. This update creates a smoother, simpler experience for patients to find the care they need, where they need it. Learn more: spklr.io/6018ERs4e

Mass General Brigham will be exhibiting at @ASTRO_org in Boston, September 27–29. Stop by to meet our experts and learn more about Mass General Brigham Cancer Institute. Visit us at Booth 2927 and see the schedule of participating experts below. #ASTRO26

That’s a wrap on #WMIF2026! Over two days, global leaders across healthcare, life sciences, technology, investment and government came together at the World Medical Innovation Forum to explore what’s next for healthcare innovation. From emerging technologies to the future of healthcare delivery, conversations centered on turning innovation into better outcomes for patients. @MGBInnovation

Extreme heat and poor air quality are already affecting our patients, and healthcare has an important role to play in building resilience. Mass General Brigham has launched The Cooperative, an initiative bringing together health care, public health, community-based organizations and government partners to develop practical solutions that help protect patients most at risk in a changing environment. Later today, The Cooperative will host its inaugural Innovation Forum as part of Climate Week NYC. Learn more: spklr.io/6018ET4F0

Help advance medical trainee well-being with evidence-based strategies. Join our course to learn how to build effective well-being programs, support trainee resilience and lead meaningful change. Register today: spklr.io/6012ETZ6Y

Where will you be in 10 months? You could be starting an exciting new career with Mass General Brigham’s Medical Laboratory Science program. Applications close on September 21, 2026 to join the January 2027 cohort. Take the first step toward your future in healthcare and apply today. spklr.io/6016ETkCE

In our Medical Laboratory Science (MLS) Training Program, students learn to identify findings like Mott cells, plasma cells filled with immunoglobulin inclusions. These can be linked to multiple myeloma, plasma cell disorders, chronic inflammation and certain infections. Training the next generation of MLS professionals helps ensure that patients continue to have life-saving cancer diagnostics. Applications for the Mass General Brigham MLS Training program are open. Apply by September 21, 2026 to join the January 2027 cohort and take the first step toward your future in healthcare. spklr.io/6017ETzpb

The new hydrotherapy room in the Patriots Training Center is special 🏊‍♂️ Take an inside look at the new spaces designed to maximize player treatment and recovery. @MassGenBrigham | #NEPats

Are you curious about a career in medical laboratory science? Get the training and preparation you need to take the Board of Certification exam with our program. Apply by September 21, 2026, and take the first step toward your future in healthcare. spklr.io/6014ErSV0

Did you know some people with a penicillin allergy label are not truly allergic? Join us for a hands-on course for providers, covering penicillin allergy assessment, including skin testing, drug challenges, and more. Register today: spklr.io/6019ErmIJ

A new study found that 1 in 4 former NFL players who died between 2016 and 2021 had evidence of CTE at the time of their death. Daniel Daneshvar, MD, PhD, lead author and chair of our Department of Physical Medicine and Rehabilitation, shares more about the study on @WBUR. spklr.io/6011ErDk3

Ashwagandha is everywhere, but what does science actually say? Jay Luthar, MD, an internal medicine doctor, shares what you should know on @HarvardHealth. spklr.io/6012ERsfq

We’re deeply grateful to the ALS Bridge Foundation for its generous $1 million gift to the Sean M. Healey & AMG Center for ALS at @MassGeneralNews

Do PRP injections for knee osteoarthritis really work? Joanne Borg Stein, MD, director of our Regenerative Medicine Program, explains what platelet-rich plasma (PRP) injections are, the latest treatment guidance and who might benefit the most. Read on @HarvardHealth: spklr.io/6016ER9vC

Mass General Brigham Cancer Institute is excited to offer patients daraxonrasib, a groundbreaking new treatment for pancreatic cancer. Only weeks after this practice-changing therapy moved beyond clinical trials, our team began administering it through a carefully coordinated process designed to ensure safe access for patients. Mary Linton Peters, MD, a medical oncologist at Mass General Brigham Cancer Institute, discusses the significance of bringing this promising treatment to patients as quickly as possible. The @BostonGlobe chronicles Lazar Mandinov's journey as he took daraxonrasib for the first time.spklr.io/6016ERgWK

We're proud to mark an important milestone in our Surgical Home Hospital journey: caring for our 500th surgical patient. This achievement reflects the dedication, expertise, and compassion of our teams and their commitment to delivering exceptional care.

At Mass General Brigham, new AI tools are helping identify eligible Home Hospital patients in real time and connecting them with personalized care more efficiently. More in @modrnhealthcr: modernhealthcare.com/post-ac…

Nearly 1 in 3 U.S. adults without heart disease may have LDL cholesterol levels above the updated 2026 guideline targets. Learn what the new research means for your heart health. spklr.io/6015Eu0L3

Help advance medical trainee well-being with evidence-based strategies. Join our course to learn how to build effective well-being programs, support trainee resilience and lead meaningful change. Register today: spklr.io/6011Eum9h

Two Mass General Brigham hospitals top their region for cancer care—@Brighamandwomens and Dana-Farber Cancer Institute and @MassGenNews rank #1 and #2 in New England by @usnews. Explore the latest treatments and technology here: spklr.io/6019Eum2H